Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


KTB Tumorforschungs GmbH

Division of University of Freiberg

Latest From KTB Tumorforschungs GmbH

Innovive Pharmaceuticals Inc.

Innovive Pharmaceuticals Inc.'s managers have strong backgrounds in cancer, which they are leveraging collectively to seek early-stage drug candidates for speedy development and marketing. The firm looks for high-value compounds that can be differentiated from others already on the market and guided quickly through development. Innovive presently has three potential cancer treatments in its pipeline.

Recent Tech Transfer Deals (10/06)

Each month, Start-Up presents a survey of technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
See All